Yield10 Bioscience

Yield10 Bioscience Cash Conversion Cycle

Cash Conversion Cycle (CCC) of Yield10 Bioscience (YTENQ) as of Nov 3, 2026.

Cash Conversion Cycle

0.00

Last updated:

Cash Conversion Cycle (CCC) of Yield10 Bioscience is 2023 0.00 . Cash Conversion Cycle (CCC) of Yield10 Bioscience was 2022 0.00 . It decreases by % lower compared to the previous year.

The Yield10 Bioscience Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2016
62.93 USD
Jan 1, 2017
38.83 USD
Jan 1, 2018
130.36 USD
Jan 1, 2019
45.06 USD
Jan 1, 2020
45.68 USD
Jan 1, 2021
118.89 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
The Yield10 Bioscience Cash Conversion Cycle history
YEARCash Conversion CycleYoY
0.00—
0.00-100.00%
118.89+160.26%
45.68+1.38%
45.06-65.43%
130.36+235.71%
38.83-38.30%
62.93-53.45%
135.19-11.18%
152.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yield10 Bioscience Stock analysis

What does Yield10 Bioscience do? Yield10 Bioscience develops Camelina sativa as a platform crop for low carbon sustainable seed products, including Camelina oil for biofuel feedstock, Omega-3 oils for nutrition, and PHA Bioplastics for biodegradable packaging. The company uses its TraitFactory platform to discover genetic traits for agriculture and food industries, focusing on herbicide tolerance and disease resistance in Camelina germplasm. Its products target petroleum replacement markets, food and nutrition sectors, and animal feed markets, with development pipelines focused on improving Camelina varieties. The company's primary products are Camelina oil, Omega-3 oils, and PHA Bioplastics, sold to markets addressing petroleum replacement, nutrition, and sustainable packaging needs. Camelina sativa serves as the core crop for all seed product development, with TraitFactory enabling trait discovery for agricultural and food applications. The firm targets industrial buyers in biofuel, nutrition, and packaging industries seeking sustainable alternatives to petroleum-based products. Yield10 Bioscience's revenue streams come from the sale of Camelina-based products to companies in the biofuel, nutrition, and packaging sectors. The company focuses on developing high-value genetic traits through TraitFactory, which are integrated into Camelina varieties for large-scale production of seed products. Its development pipeline emphasizes traits like herbicide tolerance and disease resistance to enhance crop performance and market appeal. Yield10 Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yield10 Bioscience stock

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Yield10 Bioscience since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Yield10 Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Yield10 Bioscience

All Key Metrics — Yield10 Bioscience